Involvement of Protein Kinase D in Phosphorylation and Increase of DNA Binding of Activator Protein 2α to Downregulate ATP-Binding Cassette Transporter A1

被引:21
作者
Iwamoto, Noriyuki [1 ]
Abe-Dohmae, Sumiko [1 ]
Lu, Rui [1 ]
Yokoyama, Shinji [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan
关键词
HDL; ABCA1; AP2; alpha; PKD; doxazosin; atherosclerosis;
D O I
10.1161/ATVBAHA.108.174714
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Activator protein (AP) 2 alpha negatively regulates expression of ABCA1 gene through Ser-phosphorylation of AP2 alpha(Circ Res. 2007;101:156-165). Potential specific Ser-phosphorylation sites for this reaction were investigated in human AP2 alpha. Methods and Results-The phosphorylation was shown mediated by PKD, and Ser258 and Ser326 were found in its specific phosphorylation sequence segment in AP2 alpha. PKD phosphorylated Ser258 more than Ser326 and induced its binding to the ABCA1 promoter. These reactions and AP2 alpha-induced suppression of the ABCA1 promoter activity were reversed by mutation of Ser258 more than Ser326 mutation. Knockdown of PKD by siRNA reduced the AP2 alpha Ser-phosphorylation, and increased ABCA1 expression and HDL biogenesis. Go6983 inhibited PKD more selectively than PKC in THP-1 and HEK 293 cells and in mice, and increased ABCA1 expression, HDL biogenesis, and plasma HDL level. Conclusion-PKD phosphorylates AP2 alpha to negatively regulate expression of ABCA1 gene to increase HDL biogenesis. The major functional phosphorylation of AP2 alpha was identified at Ser258 by PKD, in the AP2 alpha basic domain highly conserved among species and all 5 subtypes of AP2. PKD/AP2 system can be a potent pharmacological target for prevention of atherosclerosis. (Arterioscler Thromb Vasc Biol. 2008;28:2282-2287.)
引用
收藏
页码:2282 / 2287
页数:6
相关论文
共 43 条
[1]   Gene regulation in melanoma progression by the AP-2 transcription factor [J].
Bar-Eli, M .
PIGMENT CELL RESEARCH, 2001, 14 (02) :78-85
[2]  
Benning CM, 2002, CANCER RES, V62, P597
[3]  
Bosher JM, 1996, ONCOGENE, V13, P1701
[4]   AN ALTERNATIVELY SPLICED MESSENGER-RNA FROM THE AP-2 GENE ENCODES A NEGATIVE REGULATOR OF TRANSCRIPTIONAL ACTIVATION BY AP-2 [J].
BUETTNER, R ;
KANNAN, P ;
IMHOF, A ;
BAUER, R ;
YIM, SO ;
GLOCKSHUBER, R ;
VANDYKE, MW ;
TAINSKY, MA .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) :4174-4185
[5]  
ECKERT D, 2005, GENOME BIOL, V6
[6]   Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo [J].
Eloranta, JJ ;
Hurst, HC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (34) :30798-30804
[7]   α1-adrenergic receptor antagonists:: Novel therapy for pituitary adenomas [J].
Fernando, MA ;
Heaney, AP .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (12) :3085-3096
[8]   Intracellular cholesterol transport in synchronized human skin fibroblasts [J].
Fielding, CJ ;
Bist, A ;
Fielding, PE .
BIOCHEMISTRY, 1999, 38 (08) :2506-2513
[9]   Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation [J].
García, MA ;
Campillos, M ;
Marina, A ;
Valdivieso, F ;
Vázquez, J .
FEBS LETTERS, 1999, 444 (01) :27-31
[10]   Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of α1-adrenergic blockade [J].
González-Juanatey, JR ;
Iglesias, MJ ;
Alcaide, C ;
Piñeiro, R ;
Lago, F .
CIRCULATION, 2003, 107 (01) :127-131